Islet Holdings, Inc. (ISHI) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
Beta 1.24: the stock has moved about 24% more than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerIslet Holdings, Inc. (ISHI) trades at $0.0001. Islet Holdings, Inc. focuses on skincare products, offering a range of solutions for various skin types and concerns. The company also distributes skincare products of other brands through its online platform. Sector: Healthcare.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for ISHI: ISHI does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Islet Holdings, Inc. (ISHI) Healthcare & Pipeline Overview
Islet Holdings, Inc. operates in the skincare sector, providing a range of products from acne treatments to anti-aging solutions, alongside distributing other brands' skincare lines online. The company caters to a diverse customer base seeking specialized skincare options in a competitive market.
What Is the Investment Thesis for ISHI?
Islet Holdings, Inc. presents a high-risk, high-reward investment profile. The company's negative profit margin of -112.1% and ROE of -2168.2% indicate significant financial challenges. However, its gross margin of 57.6% suggests potential profitability if operational efficiencies improve. Growth catalysts include expanding its online presence and strategic partnerships to broaden product distribution. The company's beta of 1.24 indicates higher volatility than the market. Investors should closely monitor the company's ability to manage costs and increase revenue to achieve sustainable profitability. The absence of dividends further underscores the speculative nature of this investment.
Based on FMP financials and quantitative analysis
ISHI Key Highlights
Market Cap of $0.00B reflects the company's small size and limited investor interest.
- Gross Margin of 57.6% indicates a strong potential for profitability if operational costs are managed effectively.
- Profit Margin of -112.1% highlights significant financial challenges and the need for improved cost management.
- ROE of -2168.2% demonstrates poor return on equity, indicating inefficient use of shareholder investments.
- Beta of 1.24 suggests the stock is more volatile than the market average.
Who Are ISHI's Competitors?
ISHI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| POM Pomdoctor Limited | $1.01 | +8.61% | $6.84M | 34 5-pillar |
| MEDS TRxADE HEALTH, Inc. | $3.07 | -8.36% | $8.05M | — |
| MSLE Satellos Bioscience Inc. Common Stock | $7.54 | -6.34% | $10.5M | 33 5-pillar |
| NEUP Neuphoria Therapeutics Inc. | $3.45 | 0.00% | $18.7M | — |
| AIXC AIxCrypto Holdings, Inc. | $1.37 | +21.24% | $20.4M | — |
| RNTX Rein Therapeutics, Inc. | $0.82 | 0.00% | $23.1M | — |
| KYNB Kyntra Bio, Inc. | $5.96 | -2.13% | $24.1M | — |
| YI 111, Inc. | $3.09 | -1.90% | $27.0M | 39 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ISHI's Key Strengths?
Diverse product range.
- Established online presence.
- Distribution of other brands' products.
- Long operating history.
What Are ISHI's Weaknesses?
Small market capitalization.
- Negative profit margin.
- Limited brand recognition.
What Are the Key Risks for ISHI?
Intense competition in the skincare market could limit growth.
- Negative profit margin and ROE raise concerns about financial sustainability.
- Limited liquidity due to OTC Other listing.
- Dependence on online sales makes the company vulnerable to changes in e-commerce trends.
- Lack of regulatory oversight increases the risk of fraud or mismanagement.
What Threats Does ISHI Face?
- Intense competition in the skincare market.
- Changing consumer preferences.
- Economic downturns.
- Regulatory changes.
What Are ISHI's Competitive Advantages?
- Established brand presence since 1984.
- Diverse product range.
- Online distribution channel.
What Does ISHI Do?
Islet Holdings, Inc., originally incorporated in 1984 as Biozhem Cosmeceuticals, rebranded in May 2009 to reflect its evolving business strategy. Based in Grass Valley, California, the company focuses on developing and distributing skincare products in the United States. Their product line includes solutions for acne-prone skin, anti-aging, and sensitive skin, as well as moisturizers, toners, cleansers, and specialized botanical treatments. The company also distributes skincare products from other brands, expanding its offerings through its online platform and customer service center in Arizona. Islet Holdings, Inc. aims to provide a comprehensive range of skincare options to meet diverse customer needs, positioning itself as a versatile player in the competitive skincare market. Despite its long history, the company remains relatively small, with a limited number of employees.
What Products and Services Does ISHI Offer?
- Offers skincare products for acne-prone skin.
- Provides anti-aging skincare solutions.
- Develops products with berridroxies.
- Creates botanical skincare products.
- Offers eye treatment products.
- Provides moisturizers and creams.
- Offers products for sensitive skin.
- Distributes skincare products from other brands.
How Does ISHI Make Money?
- Develops and sells its own line of skincare products.
- Distributes skincare products from other brands.
- Generates revenue through online sales.
What Industry Does ISHI Operate In?
Islet Holdings, Inc. operates within the competitive skincare market, which is characterized by evolving consumer preferences and a constant influx of new products. The industry is driven by trends such as anti-aging solutions, natural ingredients, and personalized skincare. Competitors range from large multinational corporations to smaller niche brands. Islet Holdings differentiates itself by offering a diverse product range and distributing other brands' products. The company faces challenges in marketing, distribution, and maintaining a competitive edge in a rapidly changing market.
Who Are ISHI's Key Customers?
- Individuals with acne-prone skin.
- Individuals seeking anti-aging solutions.
- Individuals with sensitive skin.
- Customers seeking general skincare products.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
Islet Holdings, Inc. operates in the Medical - Pharmaceuticals industry within the Healthcare sector. It is headquartered in Grass Valley, US. ISHI has traded publicly since 2012.
ISHI Financials
ISHI Latest News
No recent news available for ISHI.
ISHI Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for ISHI.
Price Targets
Wall Street price target analysis for ISHI.
ISHI MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for ISHI; grades run from A+ (80-100) to F (below 30).
Leadership: J. Michael Heil
CEO
J. Michael Heil serves as the CEO of Islet Holdings, Inc. His leadership is pivotal in guiding the company's strategic direction and operational execution. With a focus on the skincare industry, Heil is responsible for overseeing the development, distribution, and marketing of the company's product line. His background includes experience in managing small teams and navigating the challenges of a competitive market. He is based in Grass Valley, California, where the company is headquartered.
Track Record: Under J. Michael Heil's leadership, Islet Holdings, Inc. has focused on maintaining its presence in the skincare market and expanding its online distribution channels. Key achievements include sustaining a diverse product range and navigating the competitive landscape. He has also overseen the company's efforts to distribute skincare products from other brands, enhancing its offerings to customers.
ISHI OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Islet Holdings, Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. This tier is often associated with higher risk due to the potential for less transparency and greater price volatility.
- OTC Tier: OTC Other
- Limited liquidity due to low trading volume.
- Lack of regulatory oversight compared to major exchanges.
- Potential for price manipulation.
- Information asymmetry due to limited disclosure.
- Higher risk of fraud or mismanagement.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's revenue and profitability trends.
- Check for any legal or regulatory issues.
- Monitor trading volume and price volatility.
- Consult with a financial advisor.
- Company has been in operation since 1984.
- Offers a range of skincare products.
- Maintains an online presence.
- Has a customer service center in Arizona.
Islet Holdings, Inc. Healthcare Stock: Key Questions Answered
What does Islet Holdings, Inc. do?
Islet Holdings, Inc. is a skincare company that develops and distributes a range of skincare products, including solutions for acne-prone skin, anti-aging, and sensitive skin. It also distributes products from other brands.
What are the main risks for ISHI?
Islet Holdings, Inc. faces several risks, including intense competition in the skincare market, which could limit its ability to gain market share and grow revenue.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited information available for this OTC-listed company.
- Financial data may not be fully up-to-date.